1. Home
  2. MCRB vs SUNS Comparison

MCRB vs SUNS Comparison

Compare MCRB & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCRB
  • SUNS
  • Stock Information
  • Founded
  • MCRB 2010
  • SUNS 2023
  • Country
  • MCRB United States
  • SUNS United States
  • Employees
  • MCRB N/A
  • SUNS N/A
  • Industry
  • MCRB Biotechnology: Pharmaceutical Preparations
  • SUNS Real Estate Investment Trusts
  • Sector
  • MCRB Health Care
  • SUNS Real Estate
  • Exchange
  • MCRB Nasdaq
  • SUNS Nasdaq
  • Market Cap
  • MCRB 141.9M
  • SUNS 153.1M
  • IPO Year
  • MCRB 2015
  • SUNS N/A
  • Fundamental
  • Price
  • MCRB $0.80
  • SUNS $11.77
  • Analyst Decision
  • MCRB Buy
  • SUNS Strong Buy
  • Analyst Count
  • MCRB 4
  • SUNS 2
  • Target Price
  • MCRB $5.63
  • SUNS $15.00
  • AVG Volume (30 Days)
  • MCRB 844.5K
  • SUNS 212.1K
  • Earning Date
  • MCRB 03-04-2025
  • SUNS 03-06-2025
  • Dividend Yield
  • MCRB N/A
  • SUNS 5.37%
  • EPS Growth
  • MCRB N/A
  • SUNS N/A
  • EPS
  • MCRB N/A
  • SUNS 0.03
  • Revenue
  • MCRB $126,325,000.00
  • SUNS $734,226.00
  • Revenue This Year
  • MCRB N/A
  • SUNS N/A
  • Revenue Next Year
  • MCRB N/A
  • SUNS $194.36
  • P/E Ratio
  • MCRB N/A
  • SUNS $340.94
  • Revenue Growth
  • MCRB 12856.41
  • SUNS N/A
  • 52 Week Low
  • MCRB $0.54
  • SUNS $8.11
  • 52 Week High
  • MCRB $1.53
  • SUNS $15.74
  • Technical
  • Relative Strength Index (RSI)
  • MCRB 46.38
  • SUNS N/A
  • Support Level
  • MCRB $0.81
  • SUNS N/A
  • Resistance Level
  • MCRB $0.84
  • SUNS N/A
  • Average True Range (ATR)
  • MCRB 0.04
  • SUNS 0.00
  • MACD
  • MCRB 0.00
  • SUNS 0.00
  • Stochastic Oscillator
  • MCRB 45.58
  • SUNS 0.00

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About SUNS Sunrise Realty Trust Inc. Common Stock

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

Share on Social Networks: